AGA Clinical Guidelines on Management of Eosinophilic Esophagitis: Accompanying Educational Presentation
Overview
AGA and the Joint Task Force on Allergy-Immunology Practice Parameters release guideline on the management of eosinophilic esophagitis (EoE). This guideline provides evidence-based recommendations for allergists and gastroenterologists focusing on the clinical management of EoE for pediatric and adult patients.
Learning objectives
- Understand that topical steroids are recommended as a first-line treatment for EoE.
- Explain proton pump inhibition (PPI) therapy, diet therapy and esophageal dilation as treatment options.
- Understand that the use of novel, targeted biologic therapies for EoE are being actively evaluated and more research is needed before these can be recommended.
Key dates
- Released date:
- May 31, 2020
- Expiration date:
- Jun 01, 2026
Pricing
Agenda
All times are Eastern.
Session Heading 1: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Session Heading 2: Lorem Ipsum Dolor sit Amet
10:00 a.m. - 5:00 p.m.
Session Sub-title 1
Person, PhD
10:00 - 11:00 a.m.
Session Sub-title 2
Person, PhD
11:00 - 12:00 midday
Session Sub-title 3
Person, PhD
12:00 - 1:00 p.m.
Course contents
Video
14 mins
Course Faculty
Faculty
Glenn Furuta, MD, AGAF
Professor, Pediatrics-Gastroenterology, Hepatology and Nutrition Director, Gastrointestinal Eosinophilic Diseases Program Aurora, Colorado
Ikuo Hirano, MD, AGAF
Division of Gastroenterology and Hepatology Northwestern University Feinberg School of Medicine Chicago, Illinois